Gastric Electrical Stimulators Market By Product (Low Frequency Gastric Stimulators and High Frequency Gastric Stimulators), By Indication (Gastroparesis and Obesity) - Growth, Future Prospects & Competitive Analysis, 2019 - 2027

Industry Outlook

The gastric electrical stimulators market is set to reach from US$ 108.3 Mn in 2018 to US$ 192.2 Mn by 2027 at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2019 to 2027. Gastric electrical stimulators are small devices which are operated by battery to promote neurostimulation in the abdominal region via lead electrodes for treatment of gastroparesis. They are also used in treating obesity by modulating the appetite and satiety in obese people resulting in weight loss. Existence of few players in the market provides a potential platform for other medical device companies to enter into the gastric electrical stimulators market. 

Market Synopsis

Gastric Electrical Stimulators Market

Get a sample copy for more information

"Excellent clinical outcomes during gastroparesis treatment and longer battery life together drive the demand for high-frequency gastric stimulators"

High-frequency gastric stimulators are spearheading the market. The chief parameters responsible for its positive market growth are excellent clinical outcomes during gastroparesis treatment such as reducing the severity of nausea & vomiting and longer battery life. Low-frequency gastric stimulators are usually employed as an external stimulator in the serosa region of stomach at 3 cycles/min to increase the amplitude of gastric slow waves and thereby improve gastric emptying time in diabetic and elderly patients.

Gastric Electrical Stimulators Market

Get a sample copy for more information

"Rising prevalence of diabetes worldwide will cause significant rise in people suffering with gastroparesis"

Gastroparesis is leading the indication segment for gastric electrical stimulators market. Gastroparesis is delayed gastric emptying primarily caused due to underlying factors such as diabetes, gastric ulcers, consumption of junk food, old age, etc. Rising prevalence of diabetes and significant rise in elderly population worldwide will rapidly increase the number of people encountering gastroparesis clinical manifestations. Obesity is on a constant rise in children and adults primarily due to increasing consumption of fast food, sedentary lifestyle, stress etc.

Gastric Electrical Stimulators Market

Get a sample copy for more information

"Rising prevalence of gastroparesis and inclination towards consumption of junk food to drive the market growth in North America"

North America is considered as the clear leader in global regional segment for gastric electrical stimulators market. It represents a market share of 42.5% due to the positive impact of major factors such as rising prevalence of gastrointestinal disorders. As per the research citing presented in a research journal of Wolters Kluwer journal the prevalence rate of gastroparesis in type 1 diabetes, type 2 diabetes and idiopathic diabetes in the United States is 16.8%, 14.0% and 13.2% respectively. Significant rise in the inclination for consumption of junk food further delays gastric emptying and provides lucrative market opportunity for gastric electrical stimulators market growth. Europe holds a market share of 35.2% on account of rising prevalence of obesity in people belonging all age group. Strategic agreement and collaboration between medical device manufacturers and clinical research institute to develop novel gastric stimulation devices to treat gastroparesis and obesity. Asia Pacific is accountable for 15.7% market share chiefly due to rising public health awareness regarding gastrointestinal disorders and developing healthcare infrastructure.

Gastric Electrical Stimulators Market

Historical & Forecast Period

This research report presents the analysis of each segment from 2017 to 2027 considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2019 to 2027.

Report Scope by Segments

The market segmentation comprises of by product, indication and geography. 

Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million

 By Product (2017–2027; US$ Mn)
 • Low-Frequency Gastric Electrical Stimulators
 • High-Frequency Gastric Electrical Stimulators

 By Indication (2017–2027; US$ Mn)
 • Gastroparesis
 • Obesity

 Geography Segment (2017–2027; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Medical device companies pioneering in gastric electrical stimulators market are Medtronic, Plc., IntraPace, Inc., ReShape Lifesciences, Inc. and Rishena Co., Ltd.

Key questions answered in this report

  • Which players are presently active in the gastric electrical stimulators market?
  • How the market assessment is performed what are the different organic and inorganic growth strategies adopted?
  • What is the prevalence rate if gastroparesis and obesity, which risk factors, are associated with it?
  • How is high frequency and low frequency utilized for treatment of gastroparesis?
  • What will be the market growth in Asia Pacific, Latin America, and MEA during the forecast period?
Choose License Type
Published Date:  Jul 2019
Category:  Medical Devices
Report ID:   59799
Report Format:   PDF
Pages:   120
Rating:    4.2 (58)
Connect With Us
24/7 Research Support